Effects of perioperative oxycodone as the sole opioid on immunity within a multi-modal analgesia framework in patients undergoing cervical cancer surgery: A randomised controlled trial

Background and Aims: Current views on oxycodone’s effects on immunity are inconsistent. Our objective was to compare the effects of perioperative oxycodone as the sole opioid in a multi-modal analgesia regimen with conventional opioid regimens on immunity in cervical cancer. Methods: In this randomi...

Full description

Saved in:
Bibliographic Details
Main Authors: Jingjing Liu, Sumeng Chen, Jianxiao Chen, Hailian Liu, Weiyi Li, Haomin Chi, Xiaowei Ding, Shaoqiang Huang
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications
Series:Indian Journal of Anaesthesia
Subjects:
Online Access:https://journals.lww.com/10.4103/ija.ija_736_24
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832086882808233984
author Jingjing Liu
Sumeng Chen
Jianxiao Chen
Hailian Liu
Weiyi Li
Haomin Chi
Xiaowei Ding
Shaoqiang Huang
author_facet Jingjing Liu
Sumeng Chen
Jianxiao Chen
Hailian Liu
Weiyi Li
Haomin Chi
Xiaowei Ding
Shaoqiang Huang
author_sort Jingjing Liu
collection DOAJ
description Background and Aims: Current views on oxycodone’s effects on immunity are inconsistent. Our objective was to compare the effects of perioperative oxycodone as the sole opioid in a multi-modal analgesia regimen with conventional opioid regimens on immunity in cervical cancer. Methods: In this randomised controlled trial (RCT), patients scheduled for laparoscopic radical hysterectomy for cervical cancer were randomised to receive either oxycodone (Group O) or conventional opioid regimens (Group C). The primary outcome was the CD4+/CD8+ ratios postoperatively at 24 and 48 h. Student’s t-test was used for normally distributed variables, the non-parametric Wilcoxon test for non-normally distributed variables, and Chi-square/Fisher’s exact test for qualitative variables, with differences significant set at P < 0.05. Results: We included 56 patients in the final analysis. The postoperative CD4+/CD8+ ratios were comparable between groups. However, the mean arterial pressures (MAPs) at extubation and 5 minutes thereafter were lower in Group O than in Group C (both P < 0.001), as were the heart rates (HRs) (P = 0.001 and 0.018, respectively). Within 24 h postoperatively, the visual analogue scale (VAS) scores for resting and movement-evoked pain were lower in Group O than in Group C (all P < 0.001), and the same was observed at 48 h postoperatively (both P = 0.002), as was the incidence of catheter-related bladder discomfort (P = 0.001). The VASs for postoperative analgesia satisfaction were higher in Group O than in Group C (P = 0.006). Conclusion: In laparoscopic surgery for cervical cancer, perioperative oxycodone as the sole opioid within a multi-modal analgesia framework does not yield anticipated benefits in immunopreservation compared to conventional opioid regimens but improves postoperative pain management and haemodynamic stability.
format Article
id doaj-art-d4fcbbb835724c79bf1f6980bcf3c382
institution Kabale University
issn 0019-5049
0976-2817
language English
publisher Wolters Kluwer Medknow Publications
record_format Article
series Indian Journal of Anaesthesia
spelling doaj-art-d4fcbbb835724c79bf1f6980bcf3c3822025-02-06T09:46:41ZengWolters Kluwer Medknow PublicationsIndian Journal of Anaesthesia0019-50490976-281769219119910.4103/ija.ija_736_24Effects of perioperative oxycodone as the sole opioid on immunity within a multi-modal analgesia framework in patients undergoing cervical cancer surgery: A randomised controlled trialJingjing LiuSumeng ChenJianxiao ChenHailian LiuWeiyi LiHaomin ChiXiaowei DingShaoqiang HuangBackground and Aims: Current views on oxycodone’s effects on immunity are inconsistent. Our objective was to compare the effects of perioperative oxycodone as the sole opioid in a multi-modal analgesia regimen with conventional opioid regimens on immunity in cervical cancer. Methods: In this randomised controlled trial (RCT), patients scheduled for laparoscopic radical hysterectomy for cervical cancer were randomised to receive either oxycodone (Group O) or conventional opioid regimens (Group C). The primary outcome was the CD4+/CD8+ ratios postoperatively at 24 and 48 h. Student’s t-test was used for normally distributed variables, the non-parametric Wilcoxon test for non-normally distributed variables, and Chi-square/Fisher’s exact test for qualitative variables, with differences significant set at P < 0.05. Results: We included 56 patients in the final analysis. The postoperative CD4+/CD8+ ratios were comparable between groups. However, the mean arterial pressures (MAPs) at extubation and 5 minutes thereafter were lower in Group O than in Group C (both P < 0.001), as were the heart rates (HRs) (P = 0.001 and 0.018, respectively). Within 24 h postoperatively, the visual analogue scale (VAS) scores for resting and movement-evoked pain were lower in Group O than in Group C (all P < 0.001), and the same was observed at 48 h postoperatively (both P = 0.002), as was the incidence of catheter-related bladder discomfort (P = 0.001). The VASs for postoperative analgesia satisfaction were higher in Group O than in Group C (P = 0.006). Conclusion: In laparoscopic surgery for cervical cancer, perioperative oxycodone as the sole opioid within a multi-modal analgesia framework does not yield anticipated benefits in immunopreservation compared to conventional opioid regimens but improves postoperative pain management and haemodynamic stability.https://journals.lww.com/10.4103/ija.ija_736_24analgesiaanalgesicscancerhaemodynamicsimmunityimmunomodulationimmunoprotectiveimmunosuppressionopioidoxycodoneuterine cervical neoplasms
spellingShingle Jingjing Liu
Sumeng Chen
Jianxiao Chen
Hailian Liu
Weiyi Li
Haomin Chi
Xiaowei Ding
Shaoqiang Huang
Effects of perioperative oxycodone as the sole opioid on immunity within a multi-modal analgesia framework in patients undergoing cervical cancer surgery: A randomised controlled trial
Indian Journal of Anaesthesia
analgesia
analgesics
cancer
haemodynamics
immunity
immunomodulation
immunoprotective
immunosuppression
opioid
oxycodone
uterine cervical neoplasms
title Effects of perioperative oxycodone as the sole opioid on immunity within a multi-modal analgesia framework in patients undergoing cervical cancer surgery: A randomised controlled trial
title_full Effects of perioperative oxycodone as the sole opioid on immunity within a multi-modal analgesia framework in patients undergoing cervical cancer surgery: A randomised controlled trial
title_fullStr Effects of perioperative oxycodone as the sole opioid on immunity within a multi-modal analgesia framework in patients undergoing cervical cancer surgery: A randomised controlled trial
title_full_unstemmed Effects of perioperative oxycodone as the sole opioid on immunity within a multi-modal analgesia framework in patients undergoing cervical cancer surgery: A randomised controlled trial
title_short Effects of perioperative oxycodone as the sole opioid on immunity within a multi-modal analgesia framework in patients undergoing cervical cancer surgery: A randomised controlled trial
title_sort effects of perioperative oxycodone as the sole opioid on immunity within a multi modal analgesia framework in patients undergoing cervical cancer surgery a randomised controlled trial
topic analgesia
analgesics
cancer
haemodynamics
immunity
immunomodulation
immunoprotective
immunosuppression
opioid
oxycodone
uterine cervical neoplasms
url https://journals.lww.com/10.4103/ija.ija_736_24
work_keys_str_mv AT jingjingliu effectsofperioperativeoxycodoneasthesoleopioidonimmunitywithinamultimodalanalgesiaframeworkinpatientsundergoingcervicalcancersurgeryarandomisedcontrolledtrial
AT sumengchen effectsofperioperativeoxycodoneasthesoleopioidonimmunitywithinamultimodalanalgesiaframeworkinpatientsundergoingcervicalcancersurgeryarandomisedcontrolledtrial
AT jianxiaochen effectsofperioperativeoxycodoneasthesoleopioidonimmunitywithinamultimodalanalgesiaframeworkinpatientsundergoingcervicalcancersurgeryarandomisedcontrolledtrial
AT hailianliu effectsofperioperativeoxycodoneasthesoleopioidonimmunitywithinamultimodalanalgesiaframeworkinpatientsundergoingcervicalcancersurgeryarandomisedcontrolledtrial
AT weiyili effectsofperioperativeoxycodoneasthesoleopioidonimmunitywithinamultimodalanalgesiaframeworkinpatientsundergoingcervicalcancersurgeryarandomisedcontrolledtrial
AT haominchi effectsofperioperativeoxycodoneasthesoleopioidonimmunitywithinamultimodalanalgesiaframeworkinpatientsundergoingcervicalcancersurgeryarandomisedcontrolledtrial
AT xiaoweiding effectsofperioperativeoxycodoneasthesoleopioidonimmunitywithinamultimodalanalgesiaframeworkinpatientsundergoingcervicalcancersurgeryarandomisedcontrolledtrial
AT shaoqianghuang effectsofperioperativeoxycodoneasthesoleopioidonimmunitywithinamultimodalanalgesiaframeworkinpatientsundergoingcervicalcancersurgeryarandomisedcontrolledtrial